HOME
LUPIN FOUNDATION
CAREERS Careers Overview Life at Lupin Campus Connect Learning & Development Current Openings P.L.E.D.G.E.
CONTACT US Contact Us Global Offices Partner With Us Lupin for Suppliers GST Information

PRESS RELEASES

Lupin Wins Five INDIASTAR 2020 Awards for Excellence in Packaging

October 23, 2020

Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules

October 06, 2020

Lupin Launches Lapatinib Tablets

September 30, 2020

Lupin Launches Fosaprepitant for Injection

September 28, 2020

Lupin Launches Atorvastatin Calcium Tablets USP

September 28, 2020

Lupin Launches Divalproex Sodium ER Tablets USP

September 22, 2020

LupinLife’s LupiSafe Announces Association with Chennai Super Kings as Official Hygiene Partner - Digital

September 16, 2020

Lupin Launches Leflunomide Tablets USP

September 02, 2020

Lupin and Mylan Launch Nepexto®, Biosimilar Etanercept in Germany

August 26, 2020

Lupin Receives Approval for Generic Albuterol Sulphate MDI

August 25, 2020

Lupin Presents Phase 3 Data for Solosec® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis

August 14, 2020

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

August 12, 2020

Lupin Launches Zileuton Extended-Release Tablets

August 11, 2020

Lupin Quarter 1 FY2021 Results

August 06, 2020

Lupin Signs Exclusive Distribution Pact with ForDoz Pharma for 2 Complex Injectable Assets Under Development

August 06, 2020

Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Mycophenolate Mofetil Tablets USP

August 06, 2020

Lupin Launches Favipiravir Drug Covihalt® for Treatment of Mild to Moderate COVID-19

August 05, 2020

Lupin Receives Tentative Approval for Empagliflozin Tablets

August 04, 2020

Lupin Receives Tentative Approval for Empagliflozin and Linagliptin Tablets

July 23, 2020

Lupin AGM E-Voting Notice

July 23, 2020

Notice to the shareholders

June 26, 2020

Lupin Receives Approval for Albendazole Tablets USP

June 11, 2020

U.S. FDA Grants Mexiletine Orphan Drug Designation

June 08, 2020

Lupin and Mylan Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept

June 04, 2020

Lupin Signs Distribution Agreement in Key EU Territories for Orphan Drug NaMuscla®

June 03, 2020

Lupin Receives Approval for Meloxicam Capsules

June 02, 2020

Lupin FY2020 Results

May 28, 2020

Lupin Receives Approval for Trientine Hydrochloride Capsules USP

May 22, 2020

Lupin Launches Authorized Generic Version of Apriso®

May 19, 2020

4QFY20 and FY20 Earnings Conference call on 29 May 2020

May 15, 2020

Lupin Extends ‘Jan Kovid’ Helpline for Bhopal and Indore Citizens

May 15, 2020

Lupin’s Vizag API Facility Receives EIR from U.S. FDA

May 14, 2020

Lupin’s Pithampur Facilities Complete Successful UK MHRA Inspection

May 08, 2020

Lupin Launches 'Jan Kovid' Helpline for Mumbai Citizens

May 06, 2020

Notice of Q4 FY2020 Board Meeting

May 05, 2020

Lupin Announces Positive Topline Results from its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis

May 04, 2020

Lupin’s Pithampur Unit-1 facility receives EIR from U.S. FDA

April 30, 2020

Lupin Receives Tentative Approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL

April 29, 2020

Lupin’s Mandideep Unit II Facility Receives EIR from U.S. FDA

April 15, 2020

Lupin’s Nagpur Facility Receives EIR from U.S. FDA

April 13, 2020

Lupin Contributes INR 21 crores Towards COVID-19 Relief Efforts

April 11, 2020

Lupin launches Mycophenolic Acid Delayed-Release Tablets USP

April 06, 2020

Lupin’s Aurangabad Facility Receives EIR from U.S. FDA

April 03, 2020

Lupin’s Inhalation Research Center, Florida receives EIR from U.S. FDA

March 30, 2020

Lupin and Mylan announce Positive European Medicines Agency opinion recommending Approval of Nepexto®, Biosimilar Etanercept

March 27, 2020

Lupin Appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs

March 26, 2020

Lupin launches Betamethasone Dipropionate Ointment USP (Augmented)

March 20, 2020

Lupin Receives International Sustainability Rating System (ISRS) Certification, 8th Edition

March 12, 2020

Lupin wins India Pharma Leader Award at India Pharma 2020 and India Medical Device 2020 Conference

March 09, 2020

Lupin Launches Authorized Generic version of Vimovo®

March 05, 2020

Lupin launches Ethacrynic Acid Tablets USP

February 25, 2020

LupinLife Collaborates With Payal Singhal and Mithali Raj at Lakmé Fashion Week 2020

February 21, 2020

U.S. FDA completes inspection of Lupin’s Aurangabad facility with Zero observation

February 18, 2020

Lupin launches Moxifloxacin Ophthalmic Solution USP 0.5%

February 14, 2020

Lupin Q3 FY2020 Results

February 06, 2020

Lupin receives approval for Leflunomide Tablets USP

February 05, 2020

Lupin’s Pithampur facilities complete successful MHRA inspection

January 27, 2020

Notice of 3QFY20 Earnings call

January 24, 2020

Notice of Q3 FY2020 Board Meeting

January 23, 2020

Lupin Foundation Wins IDMA Corporate Citizen Award 2019

January 21, 2020

Lupin and European Association of Urology Successfully Conclude Masterclass "Best of EAU19"

January 20, 2020

Lupin’s Ankleshwar Facility Wins Par Excellence Award at 33rd National Convention on Quality Concept

January 13, 2020

Lupin Appoints J. Alan Butcher as Chief Corporate Development Officer

January 10, 2020

Lupin’s Ankleshwar Facility Wins Gold Award from American Society for Quality

January 03, 2020

Lupin's Ankleshwar Facility Wins Frost & Sullivan's India Manufacturing Excellence Awards 2019

December 24, 2019

Lupin receives approval for Betamethasone Dipropionate Ointment USP (Augmented)

December 20, 2019

Lupin facilitates ‘The Best of ACG’ in association with American College of Gastroenterology

December 20, 2019

Lupin’s Alliance Partner Concord Receives Approval for Mycophenolic Acid Delayed-Release Tablets USP

December 19, 2019

Lupin launches Doxercalciferol Injection

December 19, 2019

Lupin announces completion of Kyowa divestiture to Unison

December 18, 2019

Lupin Foundation Wins Award for Excellence in Corporate Social Responsibility at India Pharma Awards 2019

December 03, 2019

Lupin Wins Award for Operational Excellence in Manufacturing at India Pharma Awards 2019

December 03, 2019

Lupin launches Hydrocortisone Valerate Cream

November 22, 2019

Lupin launches "Adhero," first-of-its-kind connected Smart Device in India to support treatment of Respiratory Disease

November 22, 2019

Lupin launches generic KCl for Oral Solution USP, 20 mEq

November 19, 2019

Lupin enters into agreement to divest its stake in Kyowa to Unison

November 11, 2019

Lupin receives US FDA approval for Zileuton Extended-Release Tablets

November 08, 2019

Dr. Desh Bandhu Gupta AAiPS Award 2019 Conferred on Dr. Umesh Gupta

November 07, 2019

Lupin Quarter II, FY 2020 Results

November 06, 2019

Lupin receives sANDA approval from US FDA for Levothyroxine Sodium Tablets USP AB ratingto Reference Listed Drug, LEVOXYL®

November 01, 2019

Notice of Q2 FY2020 Board Meeting

October 23, 2019

Lupin receives U.S. FDA approval for Divalproex Sodium ER Tablets USP

October 22, 2019

Lupin’s Nagpur facility receives EIR from the U.S. FDA

October 18, 2019

Japan’s PMDA issues GMP Certificate to Lupin’s Unit II Mandideep facility

October 09, 2019

Lupin launches Mycophenolate Mofetil Capsules USP

October 04, 2019

Lupin Appoints Johnny Mikell as Global Head of Quality

October 03, 2019

Lupin appoints Sreeji Gopinathan as Chief Information Officer

October 03, 2019

Lupin receives U.S. FDA approval for Extended Phenytoin Sodium Capsules USP

October 01, 2019

Lupin Foundation trains 7000 plus farmers at the Natural Farming Workshop in Bharatpur

October 01, 2019

Lupin launches Sildenafil Tablets USP

September 30, 2019

Lupin Appoints Jon Stelzmiller as President of US SpecialtyBusiness

September 25, 2019

Lupin receives sANDA approval from U.S. FDA for Levothyroxine Sodium Tablets USP to be considered AB rated to Reference Listed Drug, UNITHROID®

September 20, 2019

Lupin Receives Health Canada Approval for Propranolol Hydrochloride ER Capsules

September 13, 2019

Lupin receives U.S. FDA approval for Ethacrynic Acid Tablets USP

September 09, 2019

Lupin receives U.S. FDA approval for Fosaprepitant for Injection

September 06, 2019

Lupin and Boehringer Ingelheim announce Partnership to Develop and Commercialize Novel Oncology Drug to treat KRAS-driven Cancers

September 04, 2019

Lupin’s subsidiary in South Africa announces Commercial Agreement with Creso Pharma for hemp oil based cannaQIX

August 26, 2019

Lupin launches Fluoxetine Tablets USP

August 22, 2019

Lupin divests Kyowa Criticare to Neopharma group

August 22, 2019

Lupin receives U.S. FDA approval for Hydrocortisone Valerate Cream

August 16, 2019

U.S. FDA completes inspection of Lupin’s Nagpur facility

August 08, 2019

Lupin Quarter I, FY 2020 - Results

August 07, 2019

France’s ANSM completes inspection at Lupin’s Mandideep facility (Unit-1)

August 06, 2019

Lupin’s Aurangabad facility receives EIR from the U.S. FDA

August 05, 2019

Lupin’s Nagpur facility wins ENR Global Best Project Award

July 22, 2019

Lupin launches Imatinib Mesylate Tablets

July 09, 2019

Lupin receives U.S. FDA approval for Cinacalcet Tablets

July 03, 2019

Lupin receives U.S. FDA approval for Phenylephrine and Ketorolac Intraocular Solution

July 03, 2019

Lupin receives tentative U.S. FDA approval for Mirabegron ER Tablets

June 27, 2019

Japan’s PMDA completes inspection of Lupin’s Mandideep facility (Unit-2)

June 04, 2019

Lupin wins Packaging Award for its patient awareness initiative ‘Lupin Sahayak’

May 30, 2019

Lupin wins India Packaging Award for ‘Corcal Bone & Beauty’

May 29, 2019

Lupin launches Budesonide Inhalation Suspension

May 22, 2019

U.S. FDA completes inspection of Lupin’s Aurangabad facility

May 15, 2019

Fiscal year 2019 Results

May 15, 2019

Lupin receives EIR for Pharmacovigilance inspection from the U.S. FDA

May 14, 2019

Lupin launches Clobazam Tablets

May 10, 2019

Lupin and Aptissen announce exclusive distribution agreement of Synolis VA for Canada

May 09, 2019

Lupin receives tentative U.S. FDA approval for Fosaprepitant for Injection

May 07, 2019

Lupin in alliance with Natco receives FDA approval for Bosentan Tablets

April 30, 2019

Lupin receives FDA approval for Fluoxetine Tablets USP

April 16, 2019

Lupin launches Testosterone Gel

April 12, 2019

Lupin receives FDA approval for Testosterone Gel

April 11, 2019

Lupin launches Fluoxetine Tablets USP

April 10, 2019

Lupin Bioresearch Centre completes fifth successful U.S. FDA inspection

April 03, 2019

Lupin’s Pithampur Unit-3 (Indore) receives EIR from U.S. FDA

April 02, 2019

Lupin launches Tadalafil Tablets USP

April 01, 2019

Lupin appoints Ms. Christine Mundkur as an Independent Director

April 01, 2019

Lupin launches Fluocinonide Ointment USP 0.05%

March 28, 2019

Lupin receives FDA approval for Tadalafil Tablets USP

March 27, 2019

Lupin’s Pune Biotech facility receives EU GMP clearance

March 27, 2019

Lupin and YL Biologics receives PMDA approval for Etanercept biosimilar in Japan

March 26, 2019

Lupin receives FDA approval for Sildenafil Tablets USP

March 25, 2019

Lupin launches generic Levothyroxine Sodium Tablets USP

March 22, 2019

Lupin receives FDA approval for Atorvastatin Calcium Tablets USP

March 07, 2019

Lupin in alliance with Natco receives FDA approval for Imatinib Mesylate Tablets

March 05, 2019

Lupin receives FDA approval for Azacitidine for Injection, 100 mg Single-Dose Vial

February 28, 2019

Lupin launches Generic Ranolazine ER Tablets in U.S.

February 28, 2019

Lupin launches generic Minocycline Hydrochloride ER Tablets USP

February 26, 2019

Lupin receives FDA approval for Methylprednisolone Tablets USP

February 25, 2019

Lupin launches Clobazam Oral Suspension, 2.5mg/mL

February 15, 2019

Lupin receives FDA approval for Fluoxetine Tablets USP

February 12, 2019

Lupin launches Tadalafil Tablets USP

February 12, 2019

U.S. FDA completes inspection of Lupin’s Goa facility

February 11, 2019

Lupin receives FDA approval for Tadalafil Tablets USP, 20 mg

February 07, 2019

Lupin Quarter III, FY2019 - Results

February 06, 2019

Lupin launches Clomipramine Hydrochloride Capsules USP

February 05, 2019

Lupin Announces Launch of Orphan Drug NaMuscla® in Germany and the UK for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

February 01, 2019

U.S. FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility

January 28, 2019

Lupin receives FDA approval for Levothyroxine Sodium Tablets USP

January 21, 2019

LupinLife’s Corcal Bone & Beauty to launch at Lakme Fashion Week with an initiative to bring #Beautifullystrong real women to the ramp

January 18, 2019

Orphan Drug NaMuscla® Receives European Commission Approval for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

January 08, 2019

Lupin Pharmaceuticals, Inc. Issues Voluntary Recall of Ceftriaxone for Injection USP, 250mg, 500mg, 1g and 2g

January 07, 2019

Lupin receives FDA approval for Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg

January 07, 2019

Lupin receives FDA approval for Clobazam Oral Suspension, 2.5 mg/mL

December 31, 2018

Lupin and AbbVie Announce Partnership to Develop and Commercialize Novel Oncology Drug to treat Hematological Cancers

December 24, 2018

Lupin receives US FDA approval for Clobazam Tablets, 10 mg and 20 mg

December 20, 2018

Lupin receives tentative US FDA approval for Tadalafil Tablets USP, 20 mg

December 20, 2018

Lupin receives tentative US FDA approval for Dimethyl Fumarate Delayed Release Capsules, 120 mg and 240 mg

December 20, 2018

Lupin’s Pithampur Unit-3 (Indore) receives EIR from US FDA

December 20, 2018

US FDA completes inspection of Lupin’s Mandideep location

December 06, 2018

Lupin launches generic Silodosin Capsules 4mg and 8mg

December 06, 2018

Lupin launches generic Nystatin and Triamcinolone Acetonide Cream USP 100,000 units/gm; 0.1%

December 06, 2018

Lupin's Tarapur facility receives EIR from US FDA

December 06, 2018

Lupin receives FDA approval for Clomipramine HCl Capsules

December 06, 2018

Lupin receives FDA approval for KCl for Oral Solution 20 mEq

December 06, 2018

Lupin launches India's first chatbot for patients

December 06, 2018

Lupin launches generic Tetrabenazine Tablets

December 06, 2018

Lupin receives FDA approval for Decitabine for Injection, 50 mg/vial, Single-Dose Vial

December 05, 2018

Lupin receives FDA approval for Budesonide Inhalation Suspension, 0.5 mg/2 mL

November 14, 2018

Lupin launches generic Atovaquone Oral Suspension USP in the US

November 14, 2018

Lupin's Nagpur facility receives EIR from US FDA

November 14, 2018

Lupin receives FDA approval for Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials

November 14, 2018

Lupin Quarter II, FY2019 - Results

November 14, 2018

Lupin receives FDA approval for generic Triamcinolone Acetonide Ointment USP, 0.1%

November 14, 2018

Lupin Neurosciences Announces Positive CHMP Opinion for NaMuscla™ for the Treatment of Myotonia in Non-Dystrophic Myotonic Disorders

November 14, 2018

Lupin's Pithampur Unit-3 (Indore) Inspected by US FDA

November 14, 2018

Survey Data Reveals the Need for Improved Communication Between Patients and Healthcare Providers About Bacterial Vaginosis (BV), the Most Common Gynecologic Infection in the U.S.

November 14, 2018

Lupin receives tentative FDA approval for generic Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg

November 14, 2018

Lupin launches generic Clobetasol Propionate Ointment USP 0.05% in the US

November 14, 2018

Lupin launches generic Potassium Chloride Oral Solution USP, 20 mEq/15mL (10%) and 40 mEq/15 mL (20%)

November 14, 2018

Lupin appoints Alok Sonig as CEO – US Generics and Global Head – Generics R&D & Biosimilars

November 14, 2018

Lupin appoints Dr. Kamal K. Sharma as Advisor to the Company

November 14, 2018

Lupin’s Nagpur facility inspection by US FDA concluded with no observation

November 14, 2018

Lupin receives FDA approval for generic Atovaquone Oral Solution USP

November 14, 2018

Lupin’s Tarapur API Manufacturing Facility Inspected by US FDA

November 14, 2018

Lupin receives FDA approval for generic Potassium Chloride Oral Solution USP

November 14, 2018

Lupin receives FDA approval for generic Gabapentin Tablets USP, 600 mg and 800 mg

August 28, 2018

Lupin launches generic Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg

August 27, 2018

Lupin’s Nagpur facility receives Establishment Inspection Report (EIR) from US FDA

August 24, 2018

Lupin enters dermatology segment in Brazil with launch of Lupin High-End Skin Science

August 23, 2018

Lupin receives tentative FDA approval for generic Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol Valerate and Dienogest Tablets, 2 mg/2 mg and 2 mg/3 mg) Tablets

August 22, 2018

Lupin launches generic Clobetasol Propionate Cream USP 0.05% in the US

August 21, 2018

Lupin receives FDA approval for generic Hydrocortisone Butyrate Lotion, 0.1%

August 21, 2018

Quarter I, FY2019 - Results

August 08, 2018

Lupin's Mandideep facility gets approval from EDQM

July 30, 2018

Lupin launches generic Desoximetasone Topical Spray, 0.25% in the US

July 27, 2018

Lupin receives tentative FDA approval for generic Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg

July 19, 2018

Lupin's Goa facility gets approval from UK MHRA

July 16, 2018

Lupin receives FDA approval for generic Nitrofurantoin Capsules USP (Macrocrystals), 50 mg and 100 mg

July 12, 2018

Boehringer Ingelheim India and Lupin expand collaboration for co-marketing of two oral anti-diabetic drugs

July 11, 2018

Lupin appoints Yashwant Mahadik as President - Global HR

July 10, 2018

Lupin receives FDA approval for generic Hydroxychloroquine Sulfate Tablets USP, 200 mg

July 09, 2018

Lupin announces tie-up with European Association of Urology (EAU)

June 29, 2018

Lupin and MCGM Unite to launch Anti-TB Campaign in Mumbai

June 29, 2018

Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar

June 28, 2018

Lupin and Nichi-Iko announce strategic partnership for commercialization of biosimilar Etanercept in Japan

June 18, 2018

Lupin receives FDA approval for generic Drospirenone, Ethinyl Estradiol, Levomefolate Calcium Tablets and Levomefolate Calcium Tablets, 3 mg/0.02 mg/0.451 mg and 0.451 mg

June 14, 2018

Lupin launches generic Tobramycin Inhalation Solution USP in the US

June 13, 2018

Lupin receives FDA approval for generic Nystatin and Triamcinolone Acetonide Cream USP, 100,000 units/gram and 1mg/gram

June 04, 2018

Lupin launches generic Methylergonovine Maleate Tabs USP in the US

June 04, 2018

Lupin appoints Nicholas Hart as President - Specialty for US Business

May 31, 2018

Lupin launches Solosec™ (secnidazole) 2g Oral Granules in the US

May 31, 2018

Lupin submits Marketing Authorization Application for Etanercept Biosimilar in Europe

May 25, 2018

Lupin announces fiscal year 2018 Results, Board recommends dividend of 250%

May 15, 2018

Lupin's Nagpur facility US FDA inspection concluded with no observations

May 14, 2018

Lupin launches Corcal Bone and Beauty supplement

May 10, 2018

Lupin submits New Drug Application for Etanercept biosimilar in Japan

May 08, 2018

Lupin receives FDA approval for generic Temovate Ointment, 0.05%

May 07, 2018

Lupin receives FDA approval for generic Xenazine® Tablets, 12.5 mg and 25 mg

April 23, 2018

Lupin receives tentative FDA approval for generic AndroGel®, 1.62%

April 17, 2018

Lupin’s Softovac in The Economic Times ‘Promising Brands of 2018’

April 09, 2018

Lupin’s Pithampur Unit 1 facility receives Establishment Investigation report (EIR) from US FDA

April 06, 2018

Lupin’s Goa facility completes successful UK MHRA inspection

April 03, 2018

Lupin’s Pithampur Unit cleared by Health Canada

April 02, 2018

Lupin launches generic Clobex® Spray, 0.05% in the US

March 29, 2018

Lupin receives FDA approval for generic Clobex® Spray, 0.05%

March 27, 2018

Lupin launches generic Lodosyn® tablets in the US

March 26, 2018

Lupin receives FDA approval for generic Topicort Topical Spray, 0.25%

March 19, 2018

Lupin launches generic Safyral® tablets in the US

March 13, 2018

Lupin signs an agreement with CSIR-NCL and DST for the development of a continuous manufacturing process for biosimilar monoclonal antibody therapeutic (mAb)

March 08, 2018

Lupin launches generic Axiron® topical solution in the US

February 26, 2018

Lupin launches generic Namenda XR® capsules in the US

February 21, 2018

Lupin receives FDA approval for generic Tamiflu® for Oral Suspension

February 21, 2018

Lupin receives tentative FDA approval for generic Locoid® Lotion

February 12, 2018

Lupin launches generic Tamiflu® in the US

February 12, 2018

Lupin launches generic Kapvay® tablets in the US

February 08, 2018

Lupin and Yoshindo's JV – YL Biologics announces successful outcome of global Phase III study for Etanercept biosimilar in Rheumatoid Arthritis

February 07, 2018

Lupin Quarter III, FY2018 - Results

February 06, 2018

Lupin launches generic Clobex® Lotion in the US

February 01, 2018

Lupin receives FDA approval for generic Temovate Cream, 0.05%

February 01, 2018

Lupin launches generic Vibra-Tabs® Tablet in the US

January 19, 2018

Lupin forays into the OTC segment with Softovac

January 15, 2018

Lupin receives FDA approval for generic Tamiflu Capsules

January 10, 2018

Lupin launches generic Ancobon® capsules in the US

January 05, 2018

Lupin receives FDA approval for generic Dovonex Scalp Solution

December 28, 2017

Lupin receives FDA approval for generic Safyral Tablets

December 14, 2017

Lupin launches generic Acticlate® Tablets in the US

November 02, 2017

Lupin Quarter II, FY2018 - Results

October 30, 2017

Lupin receives FDA approval for generic Kapvay® Extended-Release Tablets

October 26, 2017

Lupin receives FDA approval for generic Axiron® topical solution

October 25, 2017

Lupin receives FDA approval for generic Lodosyn® tablets

October 24, 2017

Lupin Acquires Symbiomix Therapeutics LLC

October 11, 2017

Lupin launches generic Norco® tablets in the US

October 10, 2017

Lupin receives FDA approval for generic Corgard® Tablets

October 09, 2017

Lupin receives FDA approval for generic Acticlate® Tablets

September 29, 2017

Lupin receives FDA approval for generic Clobex® Lotion

September 25, 2017

Lupin appoints Jim Loerop as Chief Corporate Development Officer

September 18, 2017

Lupin receives FDA approval for generic Flagyl® Tablets

September 13, 2017

Lupin receives FDA approval for generic Vibra-Tabs® Tablet

September 11, 2017

Lupin launches generic Benicar® tablets in the US

September 04, 2017

Lupin launches generic Fosrenol Chewable Tablets in the US

August 31, 2017

NHI Drug Price Listing for Bipresso® Extended Release Tablets for the Improvement of Depressive Symptoms Associated with Bipolar Disorder Announced

August 30, 2017

Lupin launches generic Seroquel XR® tablets in the US

August 23, 2017

Lupin receives EIR from US FDA for Aurangabad, April 2017 Inspection

August 21, 2017

Lupin’s alliance partner Natco receives FDA approval for generic Fosrenol Chewable Tablets

August 14, 2017

Lupin appoints Mrs. Manju Deshbandhu Gupta as Chairman

August 11, 2017

Lupin receives FDA approval for Nikita™ (Pitavastatin) Tablets

August 09, 2017

Lupin receives FDA approval for generic Crestor® tablets

August 03, 2017

Quarter I, FY2018 - Results

August 02, 2017

Lupin receives FDA approval for generic Lidex® Ointment

August 01, 2017

Lupin’s Aurangabad facility inspection concluded by US FDA

July 31, 2017

Lupin’s Pithampur facility inspection concluded by US FDA without any observations

July 28, 2017

Lupin receives FDA approval for Fluocinonide Topical Solution

July 24, 2017

Lupin’s Goa facility inspection concluded by US FDA without any observations

July 21, 2017

American Academy of Ophthalmology and Lupin Collaborate to Enhance Continuing Ophthalmic Medical Education in India

July 11, 2017

Lupin receives FDA approval for generic Ancobon® Capsules

July 10, 2017

Lupin launches generic Vigamox® Ophthalmic solution in the US

July 07, 2017

Dr. Desh Bandhu Gupta, Founder and Chairman of Lupin passes away

June 26, 2017

Lupin launches generic Topicort® LP Emollient Cream and Topicort® Cream in the US

June 22, 2017

Lupin launches generic Wellbutrin XL® Tablets in the US

June 15, 2017

Lupin receives FDA approval for generic Roxicodone® Tablets

June 14, 2017

Quarter IV and Annual Results, FY2017

May 24, 2017

Lupin receives approval for Bepotastine Tablets - a new second generation Antihistamine

May 22, 2017

Lupin receives FDA approval for generic Seroquel XR® Tablets

May 18, 2017

Lupin and Lilly Expand Partnership in India

May 16, 2017

Lupin receives FDA approval for generic Benicar® Tablets

April 28, 2017

Lupin receives FDA approval for generic Wellbutrin XL® Tablets

April 08, 2017

Lupin launches Generic Epzicom® tablets in the US

March 29, 2017

Lupin Receives FDA Approval for Generic TOBI® Inhalation Solution

March 23, 2017

Lupin launches Generic Minastrin® 24 Fe chewable tablets in the US

March 16, 2017

Lupin launches Hydrocodone Bitartrate and Acetaminophen tablets in the US

March 09, 2017

Lupin launches Generic Paxil CR® tablets in the US

March 07, 2017

Lupin Receives FDA Approval for Generic Suprep® Bowel Prep Kit

March 03, 2017

Lupin Launches Generic Pristiq® Tablets in the US

March 02, 2017

Lupin Launches Generic Temovate® Clobetasol Propionate Scalp Application in the US

March 01, 2017

Lupin Receives FDA Approval for Generic Percocet® Tablets

February 28, 2017

Astellas and Lupin’s subsidiary Kyowa enter into an Agreement

February 27, 2017

Lupin Quarter III Results, FY2017

February 09, 2017

Lupin Receives FDA Approval for Triamcinolone Acetonide Cream

February 03, 2017

Lupin Launches Generic Ortho-Cyclen® 28 Tablets in the US

January 24, 2017

Lupin Receives FDA Approval for Generic Paxil CR® Tablets

January 23, 2017

Lupin Launches Generic MS Contin® ER Tablets in the US

January 13, 2017

Lupin Receives FDA Approval for Generic Topicort® LP Emollient Cream, 0.05% and Topicort® Cream, 0.25%

January 11, 2017

Lupin Receives FDA Approval for Generic Evoxac® Capsules

January 02, 2017

Lupin Receives Tentative Approval for Generic Livalo® Tablets

December 30, 2016

Lupin Receives Tentative Approval for Generic Giazo® Tablets

December 29, 2016

Lupin Receives Tentative Approval for Generic Benicar® Tablets

December 26, 2016

Lupin Launches Generic Vfend® Tablets and Vfend® Oral Suspension in the US

December 19, 2016

Lupin Receives FDA Approval for Generic Topicort® Ointment, 0.05%

December 14, 2016

Lupin Receives Tentative Approval for Generic Zorvolex® Capsules

December 06, 2016

Lupin Receives FDA Approval for Generic Norco® Tablets

December 05, 2016

Lupin and Eli Lilly Expand Partnership in India

December 01, 2016

Lupin Receives FDA Approval for Generic Nuvigil® Tablets

November 29, 2016

Lupin Receives Tentative Approval for Generic Epzicom® Tablets

November 23, 2016

Lupin Receives FDA Approval for Hydrocodone Bitartrate and Acetaminophen Tablets

November 17, 2016

Lupin Launches Generic Activella® Tablets in the US

November 15, 2016

Lupin Launches Novel Injectable Iron Formulation Under Brand Names “ISOFER” and “JILAZO” in India

November 11, 2016

Lupin's Quarter II, FY2017 - Results

November 09, 2016

Lupin receives EIR from US FDA for Goa, March 2016 Inspection

November 04, 2016

Lupin Receives FDA Approval for Generic Ortho-Cyclen® 28 Tablets

November 01, 2016

Type 2 Diabetes: Boehringer Ingelheim India and Lupin Announce Strategic Co-marketing Agreement

October 13, 2016

Lupin and Monosol Rx announce licensing agreement for multiple pediatric-focused products

October 06, 2016

Lupin Receives FDA Approval for Generic Namenda XR® Capsules

September 29, 2016

Lupin Receives Tentative Approval for Generic Rapaflo® Capsules

September 06, 2016

Lupin Receives Tentative Approval for Generic Avelox® Tablets

September 06, 2016

Lupin Receives Tentative Approval for Generic Zithromax® Oral Suspension

September 01, 2016

Lupin Receives Tentative Approval for Generic Paxil CR® Tablets

August 26, 2016

Lupin Receives FDA Approval for Generic Zyvox® Tablets

August 24, 2016

Lupin Receives Approval for Acotiamide Tablets to Treat Functional Dyspepsia

August 22, 2016

Lupin Receives FDA Approval for Potassium Chloride Extended-Release Capsules

August 17, 2016

Lupin Receives FDA Approval for Generic Klor-Con® Extended-Release Tablets

August 10, 2016

Record Sales & Profits - Quarter I FY2017

August 09, 2016

Lupin Acquires Branded Product Portfolio from Shionogi in Japan

August 02, 2016

Lupin Receives Tentative Approval for Generic Lexiva® Tablets, 700 mg from US FDA

July 27, 2016

Lupin Launches Generic Ortho Tri-Cyclen® Tablets in the US

July 20, 2016

US FDA Audit at Lupin’s Dabhasa Facility, 29th June – 06th July 2016

July 08, 2016

Lupin receives EIR from US FDA for Goa, July 2015 Inspection

July 07, 2016

Lupin Receives FDA Approval for Generic Activella® Tablets

June 22, 2016

Lupin Appoints Yugesh Goutam as President – Global HR

June 07, 2016

Lupin Receives FDA Approvals for Generic Vfend® Tablets 50mg, 200mg & Vfend® Oral Suspension, 40 mg/mL

June 06, 2016

Lupin announces closure of US FDA Audits for its Mandideep and Aurangabad Facilities

May 26, 2016

Record Sales & Profits – A New High Quarter IV & Annual Results - FY2016 Q4 FY2016 Net Sales up 34.0%, EBITDA up 72.7%, Net profit up 47.5% Proposed Dividend 375%

May 19, 2016

Lupin Launches Generic Femhrt® Tablets in the US

April 18, 2016

Lupin to Market new Inhaler under the brand name Loftair® in India

April 11, 2016

Lupin named amongst AON Best Employers India 2016

April 05, 2016

Lupin Appoints Dr. Kurt Nielsen as President of Lupin - Somerset

April 05, 2016

Lupin Launches Generic Intermezzo® Sublingual Tablets in the US

April 05, 2016

Lupin launches Generic Aricept tablets in the US

March 31, 2016

Lupin Completes its Acquisition of GAVIS

March 09, 2016

Quarter III Results, FY2016

February 05, 2016

Lupin Launches Generic Glumetza® HCI ER Tablets in the US

February 02, 2016

Lupin Receives FDA Approval for Generic Generess® Tablets

January 08, 2016

Lupin Launches Generic Ortho Tri-Cyclen® Lo Tablets

January 06, 2016

Lupin Receives FDA Approval for Generic Generess® Tablets

December 28, 2015

Lupin Receives FDA Approval for Potassium Chloride Extended Release Capsules

December 23, 2015

Lupin Receives FDA Approvals for Generic Loestrin® Fe 1/20 and Loestrin®1.5/30 Tablets

November 24, 2015

Lupin Appoints Thierry Volle as President - Europe, Middle-East & Africa (EMEA)

November 05, 2015

Lupin receives FDA Approval for Generic Aricept® Tablets

November 03, 2015

Lupin Receives FDA Approval for Generic Loestrin®24 Fe Tablets

November 03, 2015

Lupin Limited - Quarter II Results, FY2016

October 27, 2015

Lupin Launches Generic PhosLo® in the US

October 26, 2015

Lupin Appoints Martin Mercer as President of its Latin American Business

October 26, 2015

Lupin Appoints Fabrice Egros as President of its Asia-Pacific Business

October 23, 2015

Lupin and Boehringer Ingelheim Announce Strategic Co-marketing Agreement

October 14, 2015

Lupin launches first ever Duloxetine 40mg Delayed-Release Capsules in the US

September 03, 2015

Lupin receives FDA Approval for Generic Prilosec® Capsules

August 27, 2015

Lupin receives FDA approval for Fenofibrate Tablets, 54 mg and 160 mg

August 20, 2015

Lupin Announces New Center of Excellence for Inhalation Research in Florida

August 07, 2015

Lupin Acquires Specialty Product Portfolio in Germany

July 24, 2015

Lupin Acquires GAVIS to Expand US Generic Business

July 23, 2015

Lupin Limited - Quarter I Results, FY2016

July 23, 2015

Lupin Acquires Biocom in Russia

July 02, 2015

Lupin Acquires Medquímica in Brazi

May 13, 2015

Quarter IV and Annual Results, FY 2014-15 FY 2014-15 Net Sales up 13.6%, EBITDA up 23.7%, Net profit up 30.9%

May 13, 2015

Lupin Launches Zaxine® in Canada

April 20, 2015

Lupin Launches Generic Exforge® Tablets in the US

April 01, 2015

Lupin and Rotary Join Hands to Combat Tuberculosis in Mumbai

March 24, 2015

LUPIN COMPLETES ACQUISTION OF PHARMA DYNAMICS, SOUTH AFRICA

March 16, 2015

Lupin Receives US FDA Approval for Generic Lumigan® Ophthalmic Solution 0.03%.

February 23, 2015

Lupin Launches InspiraChamber® Anti-Static Valved Holding Chamber (VHC) in the US Expands US Brands Portfolio

February 18, 2015

Lupin and Celon Announce Strategic Development and Licensing Agreement for Generic Advair Diskusi®

February 17, 2015

Strong Margins, Robust Profits - Quarter III Results, FY 2015-2016

February 03, 2015

Lupin Receives FDA Approval for Generic Vancocin® Capsules

February 02, 2015

Lupin launches Generic DIOVAN® Tablets

January 06, 2015